In a memorandum to Medicare Advantage Organizations, the Centers for Medicare & Medicaid Services today announced new flexibility related to the use of step therapy in coverage of Part B services. The agency will allow MA plans to impose step therapy requirements for covered Part B drugs beginning in the 2019 plan year. In addition, the agency will permit those plans that also provide Part D coverage to require that a beneficiary try a Part D drug therapy prior to covering a Part B drug therapy. Federal law allows plans to use some utilization management tools, such as prior authorization; however, the agency has previously not allowed the use of step therapy, nor plans to manage coverage across the Part B and D benefits. The agency will require any plans that take advantage of this new flexibility to provide notice to beneficiaries, as well as additional care coordination services to support access to care. For more see the CMS factsheet.

Related News Articles

Headline
People enrolled in Medicare Advantage are more likely than those in traditional Medicare to report delays in care due to needed insurance approvals, according…
Headline
Andrea Preisler, AHA’s senior associate director of administrative simplification policy, explains why the recent final rule requiring Medicare Advantage,…
Headline
The Centers for Medicare & Medicaid Services yesterday released FAQs clarifying coverage criteria and utilization management requirements for Medicare…
Headline
The Centers for Medicare & Medicaid Services will accept comments through March 1 at 6 p.m. ET on its advance notice of proposed changes to Medicare…
Headline
Chris Barber, president and CEO of St. Bernards Healthcare, discusses the problems certain MA plan practices can create for patients and their caregivers,…
Headline
In a statement submitted to the House Energy and Commerce Subcommittee on Health for a hearing Jan. 31 on national health expenditures, AHA urged the…